Centre to cap profit on drugs

New Delhi: After concern expressed by the Prime Minister’s Office (PMO) on exorbitant prices of generic drugs — unbranded medicines which are sold by manufacturers through distributors without any marketing or promotion - a pharmaceuticals department panel is learnt to have suggested a significant capping on profit margin of such drugs, which could even be up to 50 per cent.

According to sources, the panel, headed by a joint secretary of the pharmaceuticals department, tabled its report and is said to have suggested capping of profit margins of manufacturers of such drugs.